| 
April 05, 2023
UroGen Pharma is yesterday's top mover after declining 8.1%
Leading equity indices in the US declined as Dow Jones was down 0.59% before closing the session at 33,400. After dropping 0.58%, S&P 500 closed at 4,100.6.
Today's price action is taking place amid mixed market indicators – United States JOLTs Job Openings (Feb) released yesterday at 14:00 UTC with a figure of 9.93 million, while the previous figure was 10.56 million.
Assets that recorded the greatest percentage change in relation to their peers are designated as "Top Movers" with 's most active healthcare stocks listed below.
Yesterday Encompass Health increased by 11.04%, ended the session at $60.07
Yesterday's session pointed in the same direction — after closing Monday at $54.1, Encompass Health Corporation closed at $60.07 yesterday after climbing to $61.35 and dropping back down. Encompass Health's market cap is currently $5.99 billion with an average daily trading volume of 978,785 shares. So far this year, it has been under-performing the Nasdaq by 13.13%.
Yesterday's slide leaves UroGen Pharma traders hoping for a bounce
An influx of sellers pushed the urothelial and specialty cancer treatment company to end the session lower around $8.96, while establishing a $8.93 to $9.79 session range yesterday. UroGen Pharma's market cap currently stands at $231.83 million with an average daily volume of 138,690 shares.
Nektar Therapeutics | Closed down 6.26% at 68.75 cents yesterday
The US biopharmaceutical company is now trading 69.26% below its 3-month high of $6.17. The company's market cap currently stands at $130 million with an average daily volume of 8.14 million shares. $22 million was Nektar Therapeutics's last reported revenue with -32 cents being the current EPS.
